Navigation Links
Pharsight to Present at B. Riley & Co. 9th Annual Las Vegas Investor Conference
Date:3/26/2008

MOUNTAIN VIEW, Calif., March 26 /PRNewswire-FirstCall/ -- Pharsight Corporation (Nasdaq: PHST), a leading provider of software, strategic consulting, and regulatory services for optimizing clinical drug development announced today that it will be presenting at B. Riley & Co. 9th Annual Las Vegas Investor Conference on April 2, 2008 at the Palms Las Vegas. Shawn O'Connor, Pharsight's President and CEO, and William Frederick, Senior Vice President and CFO, will be presenting on April 2nd, at 1:30 p.m. PT.

Attendance at the conference is by invitation only. A live audio webcast of the presentation with slides will be broadcast via the Internet. The webcast can be viewed at the company's website under the investor relations section at http://www.pharsight.com.

About Pharsight Corporation

Pharsight Corporation develops and markets integrated products and services that enable pharmaceutical and biotechnology companies to achieve significant and enduring improvements in the development and use of therapeutic products. Pharsight's goal is to help customers reduce the time, cost and risk of drug development, as well as optimize the post-approval marketing and use of pharmaceutical products.

Pharsight's approach enhances the fundamental element of drug development success: strong decision-making. By adopting the Pharsight approach, customers acquire a new decision-making process with the potential to systematically improve every level and phase of their business and scientific processes. Pharsight Corporation is headquartered in Mountain View, California. Information about Pharsight is available at http://www.pharsight.c
'/>"/>

SOURCE Pharsight Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Pharsight Makes Strong Contribution to Inaugural American Conference on Pharmacometrics
2. Pharsights Reporting and Analysis Services Business Unit to Leverage New Validated Data Management System
3. Pharsight Welcomes Newest Japanese PKS, AutoPilot Customer
4. Pharsight to Present at Jesup and Lamont 2008 Emerging Growth Stock Conference
5. Pharsight Achieves $7.4 Million in Quarterly Revenue
6. Pharsight Announces Fiscal Third Quarter 2008 Earnings Release Date and Conference Call
7. Pharsights Reporting and Analysis Services Business Reaches Quality Assurance Milestone
8. Pharsight Signs Third WinNonlin(R) AutoPilot(TM) Customer
9. Pharsight Announces 1-For-3 Reverse Stock Split
10. Pharsight Invited to Present on Oncology Modeling and Simulation at Quantitative Pharmacology Symposium in China
11. Pharsight Invited to Present on Winning Strategies for R&D Productivity at New York Pharma Forum on October 15, 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... BioTrends Research Group, one of the ... biopharmaceutical issues, finds that, unaided, one in five ... that in the past six months, they have ... anticipation of the next generation of HCV treatments—notably ... 6 percent reported that they had begun warehousing ...
(Date:5/23/2013)... BETHESDA, Md. , May 23, 2013 ... a biotechnology company developing DCVax ® personalized immune ... will use its exhibit at this year,s American Society ... to highlight its leadership role in immune ... The ASCO annual meeting is the pre-eminent conference ...
(Date:5/23/2013)...  Verenium Corporation (Nasdaq: VRNM ), a ... commercialization of high-performance enzymes, today announced that ... at two upcoming conferences. (Logo: http://photos.prnewswire.com/prnh/20120924/MM79973LOGO ... Second Annual Marcum LLP Microcap Conference on Thursday, May ... York City.  The presentation is scheduled to begin at ...
(Date:5/23/2013)... 23, 2013 SynCardia Systems, Inc. ( ... FDA, Health Canada and CE (Europe) approved Total Artificial ... Scotland, which boasts more than 380,000 visitors annually, is ... powered by the Freedom® portable driver as part of ... advanced exhibitions of its kind. , “BodyWorks combines ...
Breaking Biology Technology:The Majority of Physicians that Treat Hepatitis C Virus (HCV) Have Begun "Warehousing" and Preparing Their HCV Patients for the Next Generation of HCV Treatments 2The Majority of Physicians that Treat Hepatitis C Virus (HCV) Have Begun "Warehousing" and Preparing Their HCV Patients for the Next Generation of HCV Treatments 3NW Bio Exhibit at the Upcoming ASCO Meeting to Highlight its Leadership Role in Immune Therapy for Cancer 2NW Bio Exhibit at the Upcoming ASCO Meeting to Highlight its Leadership Role in Immune Therapy for Cancer 3Verenium To Present At Two Upcoming Conferences 2Verenium To Present At Two Upcoming Conferences 3SynCardia Total Artificial Heart Featured in $3 Million Exhibition at Glasgow Science Centre 2SynCardia Total Artificial Heart Featured in $3 Million Exhibition at Glasgow Science Centre 3
... ... ... ... ...
... ... ... ... ...
... ... ... ... ...
Cached Biology Technology:Zenith Biotech Introducing Novel StemQ(R) Hepatic and Neural Models for Use in Drug Discovery, Metabolism and Toxicology Studies, at The 49th Annual Meeting and ToxExpo In Salt Lake City, Utah, March 7-11, 2010, Booth #136 2Zenith Biotech Introducing Novel StemQ(R) Hepatic and Neural Models for Use in Drug Discovery, Metabolism and Toxicology Studies, at The 49th Annual Meeting and ToxExpo In Salt Lake City, Utah, March 7-11, 2010, Booth #136 3Zenith Biotech Introducing Novel StemQ(R) Hepatic and Neural Models for Use in Drug Discovery, Metabolism and Toxicology Studies, at The 49th Annual Meeting and ToxExpo In Salt Lake City, Utah, March 7-11, 2010, Booth #136 4Zenith Biotech Introducing Novel StemQ(R) Hepatic and Neural Models for Use in Drug Discovery, Metabolism and Toxicology Studies, at The 49th Annual Meeting and ToxExpo In Salt Lake City, Utah, March 7-11, 2010, Booth #136 5Zenith Biotech Introducing Novel StemQ(R) Hepatic and Neural Models for Use in Drug Discovery, Metabolism and Toxicology Studies, at The 49th Annual Meeting and ToxExpo In Salt Lake City, Utah, March 7-11, 2010, Booth #136 6Zenith Biotech Introducing Novel StemQ(R) Hepatic and Neural Models for Use in Drug Discovery, Metabolism and Toxicology Studies, at The 49th Annual Meeting and ToxExpo In Salt Lake City, Utah, March 7-11, 2010, Booth #136 7MO BIO Laboratories, Inc. Launches PowerBiofilm(TM) DNA and RNA Isolation Kits 2MO BIO Laboratories, Inc. Launches PowerBiofilm(TM) DNA and RNA Isolation Kits 3Concord Medical to Report Fourth Quarter and Fiscal Year 2009 Unaudited Financial Results on Thursday, March 18, 2010 2Concord Medical to Report Fourth Quarter and Fiscal Year 2009 Unaudited Financial Results on Thursday, March 18, 2010 3Concord Medical to Report Fourth Quarter and Fiscal Year 2009 Unaudited Financial Results on Thursday, March 18, 2010 4Concord Medical to Report Fourth Quarter and Fiscal Year 2009 Unaudited Financial Results on Thursday, March 18, 2010 5Concord Medical to Report Fourth Quarter and Fiscal Year 2009 Unaudited Financial Results on Thursday, March 18, 2010 6
(Date:5/24/2013)... of the world,s largest and fastest growing open-access publishers, ... Frontiers in Physics . , A broad scope journal ... provide an open-science and interactive web platform for the ... articles. , Frontiers, real-time and interactive peer-review enables ... article types. With an average of three months from ...
(Date:5/24/2013)... by avoiding detection and destruction by the immune system. ... cancer cells; however, there are many factors that cause ... cells are immune cells that function to suppress the ... Journal of Clinical Investigation , researchers led by Ronald ... that infiltrate tumors express proteins that can be targeted ...
(Date:5/24/2013)... one French Quarter neighborhood of New Orleans to determine ... Hurley, PhD, Assistant Professor of Audiology at LSU Health ... LSUHSC doctor of audiology student, recommend that people use ... case study is published online in the current issue ... important part of an audiologist,s practice is aiding patients ...
Breaking Biology News(10 mins):Frontiers launches new open-access journal in physics 2Frontiers launches new open-access journal in physics 3Please do try this at home 2
... changed its wing patterns to mimic neighbouring species and avoid ... of European scientists. The study is published today (14 August ... evolutionary thinkers, including Wallace, Bates and Darwin, have all wondered ... same patterns of warning colouration. Now for the first time, ...
... A new study shows that as climate change enhances ... could stimulate soil micro-organisms leading to a release of stored ... from the Centre for Ecology & Hydrology and the University ... August 2011) in the scientific journal Nature Climate Change ...
... Lithuania, July 6, 2011 Neurotechnology , ... introduced VeriSpeak , the company,s new voice ... VeriSpeak Software Development Kit (SDK) and as a ... 4.1 multi-biometric SDK, also announced today. VeriSpeak combines ...
Cached Biology News:Research reveals how butterflies copy their neighbors to fool birds 2Increased tropical forest growth could release carbon from the soil 2Neurotechnology Introduces VeriSpeak Voice Identification Technology 2Neurotechnology Introduces VeriSpeak Voice Identification Technology 3Neurotechnology Introduces VeriSpeak Voice Identification Technology 4
...
... Fixed clamp trays and universal ... Magnetic drive Shaking ... 25 mm amplitude ... to 2000 ml, including Fernbach flasks ...
... and Sartolab P20 plus,for Reliable Sterile Filtration ... attached to a,membrane pump or tube pump, ... liter of media,and aqueous solutions. The ... and an automatic de-aeration,ensures high flow rates ...
... allows for rapid, convenient, and efficient Denatured ... process utilizes a spin column to make ... concentration of proteins which were electro-eluted in ... ion exchangers, offering high binding capacity fo ...
Biology Products: